| Identification | Back Directory | [Name]
Acetic acid, 2-[[(1R,2S,5R)-2-(aminocarbonyl)-4-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy]-2-fluoro-, 1-methylethyl ester, (2R)- | [CAS]
2209871-83-8 | [Synonyms]
Acetic acid, 2-[[(1R,2S,5R)-2-(aminocarbonyl)-4-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy]-2-fluoro-, 1-methylethyl ester, (2R)- | [Molecular Formula]
C13H18FN3O5 | [MOL File]
2209871-83-8.mol | [Molecular Weight]
315.3 |
| Hazard Information | Back Directory | [Description]
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. |
|
|